Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Similar articles for PubMed (Select 23377510)

1.
2.

Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.

Draelos ZD, Carter E, Maloney JM, Elewski B, Poulin Y, Lynde C, Garrett S; United States/Canada Dapsone Gel Study Group.

J Am Acad Dermatol. 2007 Mar;56(3):439.e1-10. Epub 2007 Jan 17.

PMID:
17208334
3.

Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.

Tanghetti E, Dhawan S, Green L, Ling M, Downie J, Germain MA, Kasteler JS, Kircik L, Oefelein MG, Draelos Z.

J Drugs Dermatol. 2011 Jul;10(7):783-92.

PMID:
21720661
4.

Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment.

Lucky AW, Maloney JM, Roberts J, Taylor S, Jones T, Ling M, Garrett S; Dapsone Gel Long-Term Safety Study Group.

J Drugs Dermatol. 2007 Oct;6(10):981-7.

PMID:
17966175
5.

Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents.

Raimer S, Maloney JM, Bourcier M, Wilson D, Papp K, Siegfried E, Garrett S; United States/Canada Dapsone Gel Study Group.

Cutis. 2008 Feb;81(2):171-8.

PMID:
18441772
7.

Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study.

Fleischer AB Jr, Shalita A, Eichenfield LF, Abramovits W, Lucky A, Garrett S; Dapsone Gel in Combination Treatment Study Group.

J Drugs Dermatol. 2010 Jan;9(1):33-40.

PMID:
20120423
8.
9.

Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.

Shalita AR, Berson DS, Thiboutot DM, Leyden JJ, Parizadeh D, Sefton J, Walker PS, Gibson JR; Tazarotene Cream in Acne Clinical Study Investigator Group.

Clin Ther. 2004 Nov;26(11):1865-73.

PMID:
15639698
10.

Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris.

Del Rosso JQ, Kircik L, Gallagher CJ.

J Clin Aesthet Dermatol. 2015 Jan;8(1):31-7.

11.

Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.

Dréno B, Kaufmann R, Talarico S, Torres Lozada V, Rodríguez-Castellanos MA, Gómez-Flores M, De Maubeuge J, Berg M, Foley P, Sysa-Jedrzejowska A, Kerrouche N, Paliargues F, Bettoli V.

Br J Dermatol. 2011 Aug;165(2):383-90. doi: 10.1111/j.1365-2133.2011.10374.x. Epub 2011 Jul 6.

PMID:
21495995
12.

Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.

Piette WW, Taylor S, Pariser D, Jarratt M, Sheth P, Wilson D.

Arch Dermatol. 2008 Dec;144(12):1564-70. doi: 10.1001/archdermatol.2008.518.

PMID:
19075138
13.

Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.

Thiboutot D, Arsonnaud S, Soto P.

J Drugs Dermatol. 2008 Jun;7(6 Suppl):s3-10.

PMID:
18575220
14.
18.

Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.

Stotland M, Shalita AR, Kissling RF.

Am J Clin Dermatol. 2009;10(4):221-7. doi: 10.2165/00128071-200910040-00002. Review.

PMID:
19489655
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk